Secondary prevention of ischaemic stroke

Table 1 Antiplatelet therapy after non-cardioembolic stroke or transient ischaemic attack

	Options	Recommendation
AHA/ASA[25]	Aspirin (50-325 mg); aspirin plus dipyridamole; clopidogrel	Aspirin, aspirin plus dipyridamole or clopidogrel
ESO[24]	Aspirin; aspirin plus dipyridamole; clopidogrel; triflusal	Clopidogrel or aspirin plus dipyridamole
ACCP[52]	Aspirin (75-100 mg); clopidogrel; aspirin plus dipyridamole; cilostazol	Clopidogrel or aspirin plus dipyridamole

AHA/ASA: American Heart Association/American Stroke Association; ESO: European Stroke Organisation; ACCP: American College of Chest Physicians.